ESKEF yields 0.25% · PFE yields 6.13%● Live data
📍 ESKEF pulled ahead of the other in Year 1
Combined, ESKEF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ESKEF + PFE for your $10,000?
Esker SA provides SaaS-based document process automation solutions in France and internationally. The company offers procure-to-pay solutions, which includes supplier and contract management, procurement, AP automation, expense management, and payment and supply chain financing; and order-to-cash solutions, such as order and credit management, invoice delivery, payment, and collections management, as well as cash app and deductions. It also provides document delivery solutions, including cloud fax and mail, e-invoicing, and esker EDI services. In addition, the company offers document automation technologies, including Esker on Demand, a cloud-based document process and information exchange service that enables companies to automate business documents; and VSI-Fax, which provides faxing from enterprise applications along with email-integrated desktop faxing. Further, it provides host access products, which is a software enabling a group of PCs to communicate with a host system, and share peripherals, or access the associated databases; and business process outsourcing tool for incoming non-EDI orders or invoices. The company serves the life sciences, building material, food, electronics, and chemical industries. Esker SA was incorporated in 1985 and is headquartered in Lyon, France.
Full ESKEF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.